Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-480,274
Closed -$9.13M 46
2022
Q3
$9.13M Sell
480,274
-179,601
-27% -$3.56M 1% 15
2022
Q2
$11.9M Buy
659,875
+160,375
+32% +$3.69M 1.87% 10
2022
Q1
$15M Buy
+499,500
New +$15.6M 2.82% 11
2021
Q2
Sell
-60,927
Closed -$2.29M 55
2021
Q1
$2.29M Buy
60,927
+20,000
+49% +$854K 0.32% 37
2020
Q4
$1.62M Buy
40,927
+30,000
+275% +$1.23M 0.35% 24
2020
Q3
$456K Hold
10,927
0.23% 20
2020
Q2
$459K Buy
+10,927
New +$335K 0.6% 15

Other funds holding XP

Inherent Group's XP Position: Q4 2022 in Review

Inherent Group sold out of XP (XP) in Q4 2022, closing a stake of 480,274 shares — an estimated $9.13M sold.

Inherent Group first reported a position in XP in Q2 2020 and held it in 7 quarters. The position peaked at $15M in Q1 2022. 199 funds tracked by Wall St. Rank hold XP as of Q4 2022.

  • Inherent Group reported no remaining XP position as of Q4 2022 after selling out during the quarter.
  • Inherent Group sold 480,274 XP shares in Q4 2022, an estimated $9.13M.
  • Inherent Group first reported a position in XP in Q2 2020 and held it in 7 quarters.
  • Inherent Group's XP position peaked at $15M in Q1 2022.
  • 199 funds tracked by Wall St. Rank held XP as of Q4 2022.

Based on Inherent Group's 13F filing for Q4 2022, filed 14 Feb 2023.